Series Description

Chronic inflammatory demyelinating polyneuropathy (CIDP) remains a challenging, heterogeneous condition—too often underdiagnosed, misdiagnosed, or managed suboptimally. The result? Preventable progression, long-term disability, and diminished quality of life. Even with established guidelines, clinicians continue to grapple with recognizing varied presentations, applying diagnostic criteria with certainty, and navigating the limitations of current therapies. And with new biologic agents on the horizon and accelerating research on immunoglobulin G (IgG) autoantibodies and disease mechanisms, staying current has never been more essential.

CIDP Masterclass: Early Diagnosis, Emerging Options, Better Outcomes is a five-part accredited CE series delivered through the dynamic Project ECHO® collaborative learning model. Designed for neurologists, neuromuscular specialists, nurse practitioners, physician associates, pharmacists, and neurology-focused nurses, this immersive program brings together foundational knowledge, real-world case discussions, and cutting-edge insights to elevate your approach to CIDP.

Participants are encouraged to join the full learning journey to gain a cohesive, practice-transforming experience—one that equips you to diagnose earlier, treat smarter, and partner with patients for improved long-term outcomes.